|
|
|
|
|
|
|
Cardiovascular disease, the number one killer in the developed world, presents a special
urgency to pharmaceutical and medical device research. Cardiovascular disease treatment
has historically been at the forefront of pharmaceutical and medical device convergence;
drug-eluting stents set the all-time record for attaining blockbuster status. Many of our
clients' new devices are targeting indications historically treated by drugs and vice versa.
- Abdominal Aortic Aneurism (AAA)
- Acute Myocardial Infarction (AMI)
- Aneurysm
- Atherectomy
- Atherosclerosis
- Atrial Fibrillation
- Carotid Stenosis
- Congestive Heart Failure (CHF)
- Coronary Artery Bypass Grafting (CABG)
- Deep Vein Thrombosis (DVT)
- Heart Valve Replacement
- Hyperlipidemia
- Hypertension
- Ischemic Reperfusion Injury
- Percutaneous Myocardial Revascularization (PMR)
- Percutaneous Transluminal Coronary Angioplasty (PTCA)
- Peripheral Vascular Disease (PVD)
- Pulmonary Embolism (PE)
- Stable Angina
- Stroke
- Transmyocardial Revascularization (TMR)
- Unstable Angina
|
|
 |
|
|
|
|
|
learn more
about our work in cardio and peripheral vascular diseases. |
|
|
|
|
 |
|
|
|
|